Analysis of patient data reveals significantly higher ATF4 mRNA levels in neuroblastoma tumors with MYCN amplification [80] and higher ATF4 expression is associated with poor prognosis in neuroblastoma patients [81]. The gene discussed is ATF4; the disease is neuroblastoma.